These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12890160)

  • 1. Report on slide session, British Society for Haematology, 42nd annual scientific meeting, Brighton, 2002.
    Bain BJ; Winfield D; Murray J; Eden A; Psiachou-Leonard E; Gilleece M; Devalia V; Hatton C; Eagleton H; Rassan S
    Clin Lab Haematol; 2003 Aug; 25(4):221-6. PubMed ID: 12890160
    [No Abstract]   [Full Text] [Related]  

  • 2. British Society for Haematology Slide Session, Annual Scientific Meeting, Brighton, 1999.
    Bain BJ; Haynes A; Prentice AG; Luckit J; Swirsky D; Williams Y; Bhavnani M; BartonC ; Ezekwesili R
    Clin Lab Haematol; 1999 Dec; 21(6):417-25. PubMed ID: 10702015
    [No Abstract]   [Full Text] [Related]  

  • 3. The first report of chronic myelogenous leukemia with e19a2 micro-BCR/ABL1 presenting with massive myelofibrosis.
    Kim HY; Park S; Kim SH; Kim HJ
    Blood Cells Mol Dis; 2017 Jun; 65():68-70. PubMed ID: 28571780
    [No Abstract]   [Full Text] [Related]  

  • 4. Neutropenia caused by hairy cell leukemia in a patient with myelofibrosis secondary to polycythemia vera: a case report.
    Habberstad AH; Tran HTT; Randen U; Spetalen S; Dybedal I; Tjønnfjord GE; Dahm AEA
    J Med Case Rep; 2018 Apr; 12(1):105. PubMed ID: 29685167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Myeloid Leukemia With Myelofibrosis-Like Features. Clues of Accelerated Phase?
    Binotto G; Bertorelle R; Bonaldi L; Frison L; Vianello F; Pizzi M
    Int J Surg Pathol; 2019 Oct; 27(7):771-772. PubMed ID: 30813806
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chronic myeloid leukemia with progression to polycythemia vera].
    Campo MC; Fortún A; Travieso J
    Sangre (Barc); 1992 Jun; 37(3):207-8. PubMed ID: 1440100
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
    Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The splenomegaly of myeloproliferative and lymphoproliferative disorders: splenic cellularity and vascularity.
    Zhang B; Lewis SM
    Eur J Haematol; 1989 Jul; 43(1):63-6. PubMed ID: 2767243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic evaluation of myeloproliferative neoplasms.
    Azzato EM; Bagg A
    Int J Lab Hematol; 2015 May; 37 Suppl 1():61-71. PubMed ID: 25976962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
    Macavei I; Galatâr N
    Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Utility of bone marrow biopsy in the diagnosis of myeloproliferative neoplasm].
    Tovar-Bobadilla JL; Ortiz-Hidalgo C
    Gac Med Mex; 2016; 152(3):407-18. PubMed ID: 27335198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycythemia vera followed by hairy cell leukemia variant.
    Kotchetkov R; Gupta V
    Blood; 2012 Dec; 120(26):5100. PubMed ID: 23387002
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neutrophil alkaline phosphatase score].
    Nakamura Y; Waga K; Mitani K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():785-8. PubMed ID: 15658450
    [No Abstract]   [Full Text] [Related]  

  • 14. Hairy cell leukemia variant transforming into aggressive lymphoma with prostatic involvement in a patient with polycythemia vera.
    Razaq M; Perumandla S; Mankan N; Sridhar S; Sanmugarajah J; Fernandez G; Hussain S
    Leuk Lymphoma; 2006 Apr; 47(4):754-7. PubMed ID: 16886275
    [No Abstract]   [Full Text] [Related]  

  • 15. A fertile XY/XX chimeric male with chronic myeloid leukemia in a minor 46,XX cell line and a history of polycythemia vera and trisomy 9 in the major 46,XY cell line.
    Reddy KS; Schwartz GE; Jamedhor M
    Leuk Lymphoma; 2009 Aug; 50(8):1375-80. PubMed ID: 19562617
    [No Abstract]   [Full Text] [Related]  

  • 16. British Society for Haematology, slide session, Annual Scientific Meeting, Edinburgh, 2006.
    Bain BJ
    Clin Lab Haematol; 2006 Dec; 28(6):363-9. PubMed ID: 17105488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and therapy of chronic myeloproliferative disorders].
    Kimura A
    Nihon Naika Gakkai Zasshi; 1998 Mar; 87(3):507-12. PubMed ID: 9577584
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
    Tefferi A
    Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic myeloproliferative syndromes].
    de Ozalla CB; García Suárez J
    Rev Clin Esp; 1999 Apr; 199 Suppl 1():28-36. PubMed ID: 10422448
    [No Abstract]   [Full Text] [Related]  

  • 20. Neutrophilic myelofibrosis presenting as Philadelphia chromosome negative BCR non-rearranged chronic myeloid leukemia.
    Stewart K; Carstairs KC; Dubé ID; Keating A
    Am J Hematol; 1990 May; 34(1):59-63. PubMed ID: 2327406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.